Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: Clinical Evaluation of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement (CADENCE)

View source ↗

Summary

The CADENCE clinical evaluation of the Integra Cadence Total Ankle System for primary ankle joint replacement is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Integra Cadence Total Ankle System

Snippet

Sponsor: Smith & Nephew, Inc. | Conditions: Rheumatoid Arthritis, Degenerative Arthritis | Status: SUSPENDED